LONDON, Oct 21 (Reuters) - GlaxoSmithKline's chiefexecutive is joining a new panel to promote trade betweenBritain and China, just over a year after the drugmaker washanded a record fine of nearly $500 million for bribing Chinesedoctors.
The group has since been rebuilding its position in China.
The move came as Britain announced the signing of more than2 billion pounds ($3.1 billion) of healthcare trade dealsbetween Chinese and UK companies, universities and organisationsduring President Xi Jinping's visit to Britain.
In addition to GSK's Andrew Witty, the China-BritainBusiness Council said on Wednesday its new 30-strong advisorycouncil would also include WPP CEO Martin Sorrell,Jaguar Land Rover boss Ralf Speth, Rio Tinto CEO Sam Walsh and HSBC Chairman Douglas Flint.($1 = 0.6475 pounds) (Reporting by Ben Hirschler; Editing by Pravin Char)
Rio Tinto (RIO)
HSBC Holdings (HSBA)
Glaxosmithkline (GSK)
WPP (WPP)
